Paper167941
Carcinogenicity of nitrosation products of ephedrine, sarcosine, folic acid, and creatinine.
Wogan GN and 3 others. Cancer Res, 1975. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Carcinogenicity of nitrosation products of ephedrine, sarcosine, folic acid, and creatinine. Papers, record 167941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/167941
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Carcinogenicity of nitrosation products of ephedrine, sarcosine, folic acid, and creatinine.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinogens | Major topic |
| Carcinoma | Major topic |
| Liver Neoplasms | Major topic |
| Lung Neoplasms | Major topic |
| Nitroso Compounds | Major topic |
| Adenoma, Bile Duct | |
| Animals | |
| Creatinine | |
| Ephedrine | |
| Folic Acid | |
| Hyperplasia | |
| Lethal Dose 50 | |
| Mice | |
| Mice, Inbred C3H | |
| Mice, Inbred C57BL | |
| Neoplasms, Experimental | |
| Neurofibroma | |
| Nitro Compounds | |
| Precancerous Conditions | |
| Sarcosine |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40639678 | Genotoxicity evaluation of ten nitrosamine drug substance-related impurities using 2D and 3D HepaRG cell models. | Regul Toxicol Pharmacol | 2025 | https://conductscience.org/library/papers/40639678 | PubMed |
| 39433234 | Mutagenicity and genotoxicity evaluation of 15 nitrosamine drug substance-related impurities in human TK6 cells. | Regul Toxicol Pharmacol | 2024 | https://conductscience.org/library/papers/39433234 | PubMed |
| 39343352 | Optimizing the detection of N-nitrosamine mutagenicity in the Ames test. | Regul Toxicol Pharmacol | 2024 | https://conductscience.org/library/papers/39343352 | PubMed |
| 36999063 | Risk assessment of N-nitrosamines in food. | EFSA J | 2023 | https://conductscience.org/library/papers/36999063 | PubMed |
| 21432386 | Genotoxic effects of N-nitrosoketamine and ketamine as assessed by in vitro micronucleus test in Chinese hamster lung fibroblast cell line. | Environ Health Prev Med | 2006 | https://conductscience.org/library/papers/21432386 | PubMed |
| 4068803 | Vitamin deficiency and cancer. | Med Oncol Tumor Pharmacother | 1985 | https://conductscience.org/library/papers/4068803 | PubMed |
| 588420 | A method for detecting carcinogenic organic chemicals using mammalian cells in culture. | Br J Cancer | 1977 | https://conductscience.org/library/papers/588420 | PubMed |
| 354672 | An evaluation of 6 short-term tests for detecting organic chemical carcinogens. | Br J Cancer | 1978 | https://conductscience.org/library/papers/354672 | PubMed |
| 98173 | Structural analysis as a means of predicting carcinogenic potential. | Br J Cancer | 1978 | https://conductscience.org/library/papers/98173 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/167941
GET https://conductscience.org/api/papers/v1/167941/authors